Moderna (MRNA) - Stock Price & Dividends

Moderna Inc (NASDAQ:MRNA) is a biotechnology company based in Cambridge, Massachusetts. The company is focused on developing messenger RNA therapeutics and vaccines for a range of health conditions, including infectious diseases, immuno-oncology, rare diseases, autoimmune disorders, and cardiovascular diseases. Moderna operates not only in the United States but also in Europe and internationally, aiming to bring innovative solutions to global health challenges.

Moderna's extensive portfolio includes various vaccines, such as those for COVID-19, influenza, respiratory syncytial virus, as well as spikevax and hMPV/PIV3 vaccines. The company also works on developing vaccines for latent viruses like cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus, in addition to public health vaccines such as Zika and Nipah vaccines.

Moreover, Moderna offers a range of therapeutics including systemic secreted and cell surface treatments, cancer vaccines like personalized cancer, KRAS, and checkpoint vaccines, intratumoral immuno-oncology products, and various other treatments for different conditions. The company has established key partnerships with organizations like AstraZeneca, Merck, and The Bill & Melinda Gates Foundation to further advance its research and development efforts in the biotechnology sector.

Originally known as Moderna Therapeutics, Inc., the company transitioned to Moderna, Inc. in August 2018. Since its founding in 2010, Moderna has been dedicated to pioneering new approaches in biotechnology to address global health needs. For more information about Moderna, Inc., you can visit their website at https://www.modernatx.com.